Luke H. Rhym

1.5k total citations · 1 hit paper
12 papers, 802 citations indexed

About

Luke H. Rhym is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Luke H. Rhym has authored 12 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Infectious Diseases. Recurrent topics in Luke H. Rhym's work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (5 papers) and RNA and protein synthesis mechanisms (3 papers). Luke H. Rhym is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (5 papers) and RNA and protein synthesis mechanisms (3 papers). Luke H. Rhym collaborates with scholars based in United States, Canada and China. Luke H. Rhym's co-authors include Daniel G. Anderson, Frank DeRosa, James C. Kaczmarek, Michael W. Heartlein, Rajith S. Manan, Antonius Koller, Yueying Cao, David R. Liu, Wen Xue and Tingting Jiang and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Biomaterials.

In The Last Decade

Luke H. Rhym

11 papers receiving 792 citations

Hit Papers

Enhancing the immunogenicity of lipid-nanoparticle mRNA v... 2023 2026 2024 2025 2023 25 50 75

Peers

Luke H. Rhym
Michaela Jeong South Korea
Timothy Racie United States
William Cantley United States
Mustafa M. Munye United Kingdom
Antony Jozić United States
Michaela Jeong South Korea
Luke H. Rhym
Citations per year, relative to Luke H. Rhym Luke H. Rhym (= 1×) peers Michaela Jeong

Countries citing papers authored by Luke H. Rhym

Since Specialization
Citations

This map shows the geographic impact of Luke H. Rhym's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke H. Rhym with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke H. Rhym more than expected).

Fields of papers citing papers by Luke H. Rhym

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke H. Rhym. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke H. Rhym. The network helps show where Luke H. Rhym may publish in the future.

Co-authorship network of co-authors of Luke H. Rhym

This figure shows the co-authorship network connecting the top 25 collaborators of Luke H. Rhym. A scholar is included among the top collaborators of Luke H. Rhym based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke H. Rhym. Luke H. Rhym is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Berger, Nicolas, et al.. (2025). A novel gene therapy platform for the treatment of type 2 diabetes and obesity. Molecular Therapy — Nucleic Acids. 36(4). 102739–102739.
2.
Rhym, Luke H., et al.. (2023). Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery. Nature Biomedical Engineering. 7(7). 901–910. 81 indexed citations
3.
Li, Bowen, Allen Yujie Jiang, Theresa M. Raimondo, et al.. (2023). Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA. Nature Biomedical Engineering. 9(2). 167–184. 98 indexed citations breakdown →
4.
Rhym, Luke H. & Daniel G. Anderson. (2022). Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art. Med. 3(3). 167–187. 27 indexed citations
5.
Kaczmarek, James C., Asha K. Patel, Luke H. Rhym, et al.. (2021). Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles. Biomaterials. 275. 120966–120966. 94 indexed citations
6.
Leboeuf, Dominique, Tatiana O. Abakumova, Luke H. Rhym, et al.. (2020). Downregulation of the Arg/N-degron Pathway Sensitizes Cancer Cells to Chemotherapy In Vivo. Molecular Therapy. 28(4). 1092–1104. 24 indexed citations
7.
Taylor, James A., Alexandre Savard, Hui‐Shan Guo, et al.. (2020). Reduction of the therapeutic dose of silencing RNA by packaging it in extracellular vesicles via a pre-microRNA backbone. Nature Biomedical Engineering. 4(1). 52–68. 129 indexed citations
8.
Jiang, Tingting, Jordana M. Henderson, K. Coote, et al.. (2020). Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope. Nature Communications. 11(1). 1979–1979. 82 indexed citations
9.
Song, Chun‐Qing, Tingting Jiang, Michelle F. Richter, et al.. (2019). Adenine base editing in an adult mouse model of tyrosinaemia. Nature Biomedical Engineering. 4(1). 125–130. 138 indexed citations
10.
Fenton, Owen S., Kevin Kauffman, Rebecca L. McClellan, et al.. (2018). Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs. Angewandte Chemie. 130(41). 13770–13774. 16 indexed citations
11.
Fenton, Owen S., Kevin Kauffman, Rebecca L. McClellan, et al.. (2018). Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs. Angewandte Chemie International Edition. 57(41). 13582–13586. 100 indexed citations
12.
Kotanen, Christian N., Dileep R. Janagam, Luke H. Rhym, et al.. (2015). Partitioning of coomassie brilliant blue into DMAEMA containing poly(HEMA)-based hydrogels. European Polymer Journal. 72. 438–450. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026